USD 1.9 billion
Endoscopic Retrograde Cholangiopancreatography Market Size, Share, Growth Analysis, By Product type(Endoscopes, Endo-therapy Devices, Imaging Systems, Energy Devices), By Application(Biliary Sphincterotomy, Biliary Stenting, Biliary Dilatation, Pancreatic Duct Stenting), By End user(Hospitals & Clinics, Ambulatory Surgical Centers), By Region - Industry Forecast 2025-2032
Report ID:
SQMIG35A2748 |
Region:
Global |
Published Date: July, 2027
Pages:
219
|Tables:
91
|Figures:
67
Endoscopic Retrograde Cholangiopancreatography Market Insights
Endoscopic Retrograde Cholangiopancreatography Market size was valued at USD 2.09 Billion in 2023 and is poised to grow from USD 2.29 Billion in 2024 to USD 4.84 Billion by 2032, growing at a CAGR of 9.80% during the forecast period (2025-2032).
The advent of minimally invasive surgical techniques has significantly increased the demand for endoscopic retrograde cholangiopancreatography (ERCP) procedures, paving the way for a thriving industry in the upcoming years. The surge in patients seeking ERCP operations is notably influenced by the advantages of minimally invasive approaches, which offer reduced recovery times and fewer complications compared to traditional surgical methods.
According to the American Cancer Society's annual report released in January 2023, the United States is expected to see an estimated 41,210 new cases of liver cancer, further emphasizing the critical need for advanced diagnostic and therapeutic interventions.
Market snapshot - 2024-2031
Global Market Size
Largest Segment
Hospitals and Clinics
Fastest Growth
Ambulatory Surgical Centers
Growth Rate
9.80% CAGR
Endoscopic Retrograde Cholangiopancreatography Market ($ Bn)
Country Share for North America Region (%)
To get more reports on the above market click here to Buy The Report
Endoscopic Retrograde Cholangiopancreatography Market Segmental Analysis
Endoscopic retrograde cholangiopancreatography market is segmented based on product type, Procedure, end user, and region. Based on product type, the market is segmented into endoscopes, endotherapy devices, imaging systems, energy devices, and others. Based on application, the market is segmented into Biliary Sphincterotomy, Biliary Stenting, Biliary Dilatation, Pancreatic Duct Stenting, Pancreatic Duct Dilatation, Pancreatic Sphincterotomy. Based on end user, the market is segmented into hospitals & clinics and ambulatory surgical centers, and others. Based on region, the market is segmented into North America, Europe, APAC, Middle East and Africa, LATAM.
Analysis by End-User
The category of hospitals and clinics emerged as the primary revenue generator in the market, experiencing notable growth driven by several factors. A significant contributor to this increase is the rapid expansion of healthcare infrastructure, particularly in North America and Europe. The bolstered financial growth of hospitals in these regions is a direct outcome of this accelerated development, reflecting the heightened emphasis on healthcare services. The market's expansion is further propelled by the escalating demand from patients for hospital-based care utilizing advanced medical tools such as sphincterotomes.
The ambulatory surgical centers (ASCs) segment plays a crucial role in shaping the landscape of the endoscopic retrograde cholangiopancreatography (ERCP) market. ASCs serve as vital healthcare facilities that offer specialized outpatient surgical procedures, providing a convenient and efficient alternative to traditional hospital-based care. In the context of ERCP, ASCs contribute significantly to expanding patient access to this diagnostic and therapeutic procedure. The role of ASCs is particularly noteworthy in facilitating timely and cost-effective interventions for pancreatobiliary diseases.
Analysis by Procedure
The biliary sphincterotomy segment stands proud as a dominant force in the marketplace, marked via its prevalence and significance in therapeutic endoscopy. This method includes the software of an excessive-frequency modern to sever both the biliary sphincter and the intraduodenal portion of the not unusual bile duct. The technique starts with selective cannulation using a sphincterotome—a specialized knife specifically designed for this motive and inserted into the papilla.
The biliary dilatation section performs a critical and specialized role within the endoscopic retrograde cholangiopancreatography (ERCP) marketplace, addressing specific conditions related to the dilation of the bile ducts. Biliary dilatation is a centered therapeutic thing of ERCP that entails the cautious enlargement of narrowed or obstructed bile ducts, commonly caused by factors consisting of strictures, stones, or tumors. This phase is fundamental in offering specific and tailor-made interventions to relieve obstructions and restore ordinary bile float.
Endoscopic Retrograde Cholangiopancreatography Market By End User
To get detailed analysis on other segments, Request For Free Sample Report
Endoscopic Retrograde Cholangiopancreatography Market Regional Insights
North America is poised to assert dominance inside the endoscopic retrograde cholangiopancreatography (ERCP) market, driven by using several key factors. The market's expansion in North America is substantially propelled via full-size studies in diagnostic imaging, showcasing a dedication to advancing medical technology and improving diagnostic precision. The rapid introduction of technologically superior ERCP tools, consisting of sphincterotomes, is an indicator of the place's willpower to innovation in healing endoscopy.
Asia-Pacific is anticipated to show off the fastest CAGR in the endoscopic retrograde cholangiopancreatography (ERCP) market from 2024 to 2031. The driving force in the back of this boom is more often than not attributed to the expansive improvement of the healthcare industry inside the area. As healthcare infrastructure keeps adapting and increasing, there is a concurrent rise within the call for superior scientific techniques and technology, such as ERCP. Additionally, the growth of the ERCP market inside the Asia-Pacific location is fueled with the aid of an increasing attention to the efficacy of sphincterotomes within the remedy of pancreatic and liver problems.
Endoscopic Retrograde Cholangiopancreatography Market By Region
- Largest
- Fastest
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Endoscopic Retrograde Cholangiopancreatography Market Dynamics
Drivers
Rising Application of ERCP is Boosting Market Growth
- ERCP, or endoscopic retrograde cholangiopancreatography, is a specialized clinical system designed for both the identity and treatment of issues affecting the pancreas, liver, gallbladder, and bile ducts. This diagnostic and therapeutic technique integrates luminal endoscopy with fluoroscopy-based imaging, supplying a comprehensive technique to addressing pancreatobiliary illnesses. The technique entails the utilization of an endoscope—a flexible, elongated, and illuminated tube—mixed with X-ray era. The endoscope is carefully guided through the digestive system, bearing in mind direct visualization of the centered organs and systems. Simultaneously, X-ray images are captured to offer distinctive records approximately the pancreas, liver, gallbladder, and bile ducts.
Restraints
High Cost of ERCP Devices
- The expansion of the marketplace is being hindered by stringent authorities guidelines imposed by means of regulating our bodies in several nations, which pose challenges for the advent of new technology. Compliance with those policies needs rigorous trying out and adherence to safety and efficacy standards, contributing to a complex and time-ingesting approval procedure for brand new scientific technology. Despite those regulatory hurdles, the marketplace is experiencing some high quality influences. The upward push in disposable income, specifically in developing nations, has ended up a driving force for market increase.
Request Free Customization of this report to help us to meet your business objectives.
Endoscopic Retrograde Cholangiopancreatography Market Competitive Landscape
The competitive environment of the global Endoscopic Retrograde Cholangiopancreatography market is dynamic and characterized by the presence of a mix of well-established brands, emerging players, and niche producers. Innovation is a key competitive factor. Leading brands invest in research and development to introduce new flavors, packaging formats, and health-focused variations to cater to changing consumer preferences. They often set the trends in the industry.
Top Player’s Company Profiles
- Olympus Corporation
- CONMED Corporation
- HOYA Corporation
- Fujifilm Holdings Corporation
- KARL STORZ SE & Co. KG
- Ambu A/S
- Johnson & Johnson
- Boston Scientific Corporation
- Medtronic PLC
- Cook Medical
- B. Braun Melsungen AG.
Recent Developments
- In February 2023, BD made a full-size stride in medical innovation with the introduction of the High-Throughput Single-Cell Multiomics Platform. This cutting-edge platform is designed to significantly increase the scope of clinical discovery by permitting researchers to investigate and recognize unmarried-mobile multi omics records at a high throughput. The introduction of this platform reflects BD's commitment to advancing clinical research and facilitating breakthroughs in numerous fields.
- In February 2023, Boston Scientific received approval from the U.S. Food and Drug Administration (FDA) for its LithoVue Elite Single-Use Digital Flexible Ureteroscope System. This FDA approval underscores the machine's compliance with rigorous protection and efficacy standards, positioning it as a reliable and superior scientific tool for urological approaches.
Endoscopic Retrograde Cholangiopancreatography Key Market Trends
- The trajectory of the marketplace is predicted to experience significant propulsion via strategic projects undertaken by means of key enterprise gamers, which includes impactful measures together with product launches, mergers, and acquisitions. A noteworthy instance is the strategic distribution agreement solid between Olympus and EndoClot Plus in April 2022. EndoClot Plus, specializing in hemostasis technology, introduced the EndoClot PHS—a nonthermal, nontraumatic technique designed for rapid and reliable hemostasis in gastrointestinal bleeds. This collaboration is indicative of the marketplace's dedication to advancing current solutions in healing endoscopy.
Endoscopic Retrograde Cholangiopancreatography Market SkyQuest Analysis
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyzes the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
Global Endoscopic Retrograde Cholangiopancreatography marketplace analysis exhibits a dynamic marketplace with some of standout developments and problems. The healthcare industry is witnessing a good sized increase pushed through initiatives undertaken via numerous organizations, in particular through strategic partnerships centered on studies and development of revolutionary products. An illustrative instance comes from a studies article posted in the Optica Publishing Group magazine in July 2022.
| Report Metric | Details |
|---|---|
| Market size value in 2022 | USD 1.9 billion |
| Market size value in 2031 | USD 4.41 billion |
| Growth Rate | 9.80% |
| Base year | 2023 |
| Forecast period | 2024-2031 |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
- Exhibit: Executive Summary – Chart on Market Overview
- Exhibit: Executive Summary – Data Table on Market Overview
- Exhibit: Executive Summary – Chart on Endoscopic Retrograde Cholangiopancreatography Market Characteristics
- Exhibit: Executive Summary – Chart on Market by Geography
- Exhibit: Executive Summary – Chart on Market Segmentation
- Exhibit: Executive Summary – Chart on Incremental Growth
- Exhibit: Executive Summary – Data Table on Incremental Growth
- Exhibit: Executive Summary – Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on Endoscopic Retrograde Cholangiopancreatography Market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Competitive rivalry
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Total number of companies covered
Methodology
For the Endoscopic Retrograde Cholangiopancreatography Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Endoscopic Retrograde Cholangiopancreatography Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Endoscopic Retrograde Cholangiopancreatography Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Endoscopic Retrograde Cholangiopancreatography Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
Endoscopic Retrograde Cholangiopancreatography Market Report Snapshots
- Endoscopic Retrograde Cholangiopancreatography Companies
- Endoscopic Retrograde Cholangiopancreatography Market Size
- Endoscopic Retrograde Cholangiopancreatography Market Analysis
- Endoscopic Retrograde Cholangiopancreatography Geographic Analysis
- Endoscopic Retrograde Cholangiopancreatography Market News
USA (+1) 351-333-4748
